Advanced Lung Adenocarcinoma (LUAD) Patient with EGFR Mutations Benefited from Multiline Combination Targeted Therapies after Osimertinib (AZD9291) Resistance: a Case Report
Translational Cancer Research（2022）
关键词
Lung adenocarcinoma (LUAD),osimertinib,MET amplification,brigatinib and cetuximab,case report
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要